StonvexLoading…
StonvexCore line items from CGC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$269.00M | C$297.15M | C$333.25M | C$315.37M |
Operating Income | C$-117.14M | C$-228.71M | C$-2.63B | C$-2.24B |
Net Income | C$-598.12M | C$-657.27M | C$-3.28B | C$-2.64B |
EPS (Diluted) | C$-5.56 | C$-8.79 | C$-70.69 | C$-5.82 |
Total Assets | C$917.70M | C$1.30B | C$2.44B | C$2.94B |
Total Liabilities | C$430.49M | C$799.82M | C$1.68B | C$1.58B |
Cash & Equivalents | C$113.81M | C$170.30M | C$667.69M | Not available |
Free Cash Flow OCF − CapEx | C$-176.56M | C$-285.40M | C$-566.66M | Not available |
Shares Outstanding | 183.87M | 91.12M | 51.73M | Not available |